ASCO’s New MACRA Decision Tree Tool Helps Determine Which QPP Reporting Requirements Apply to Your Practice


Get Permission

Believe it or not, we’re halfway through the 1st year of the Quality Payment Program (QPP). ASCO, the Centers for Medicare & Medicaid Services (CMS), and other stakeholders have released guidance on successfully complying with QPP, but tailored information addressing a practice’s specific circumstances during this transition period can be harder to find. 

ASCO has developed a MACRA decision tree tool to help oncology practices find precise information on their QPP participation status and any applicable Merit-Based Incentive Payment System (MIPS) exceptions, based on practice– or provider-specific information. With answers to a few basic questions, the tool can help determine the participation status of everyone in a practice; identify performance categories from which providers may be exempt or have lessened reporting requirements; and identify differences in reporting requirements for specific individuals depending on whether they choose individual or group reporting.

The decision tree can answer:

  • Am I subject to MACRA and QPP?
  • Do I participate in a CMS-recognized Advanced Alternative Payment Model (APM)?
  • Am I a MIPS-eligible clinician?
  • Do I participate in a MIPS APM (a specific type of APM that does not meet the requirements to be an Advanced APM)?
  • Do any exemptions or special circumstances apply to me (includes factors such as professional designation, number of Medicare patients seen annually, practice site(s), and the size of the practice)?
  • Do these exemptions or special circumstances affect decisions regarding individual vs group reporting?

Access the decision tree at ASCO.org/MACRA

More on MACRA

For more than 2 years, oncology practices have been preparing for implementation of the Medicare Access and CHIP Reauthorization Act (MACRA), which is completely transforming the way practices are reimbursed for Medicare Part B services. QPP, established by MACRA, launched in January 2017. Visit ASCO in Action at ascoaction.asco.org for breaking cancer policy developments and the latest on MACRA implementation. ■

© 2017. American Society of Clinical Oncology. All rights reserved.



Advertisement

Advertisement



Advertisement